Akoya to Participate at Four Upcoming Investor Conferences

Rhea-AI Summary

Akoya Biosciences (Nasdaq: AKYA) will participate in four upcoming investor conferences, showcasing its advancements in spatial biology.

The events include:

• H.C. Wainwright 24th Annual Global Investment Conference - September 12 at 11:30 AM ET
• Morgan Stanley 20th Annual Global Healthcare Conference - September 14 at 8:35 AM ET
• Capital One Spatial Biology & Proteomics Summit - September 28 at 10:15 AM and 1:00 PM ET
• Bank of America Healthcare Innovation Forum - September 29 at 11 AM ET

Webcasts of the events will be available on Akoya's website.

MARLBOROUGH, Mass., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will be participating in four upcoming investor conferences.

• H.C. Wainwright 24^th Annual Global Investment Conference (New York, NY)
  Presentation on Monday, September 12^th at 11.30 AM ET
  

• Morgan Stanley 20^th Annual Global Healthcare Conference (New York, NY)
  Fireside chat on Wednesday, September 14^th at 8:35 AM ET
  

• Capital One Spatial Biology & Proteomics Summit (Virtual)
  Spatial Biology & Single Cell panel discussion on Wednesday, September 28^th at 10:15 AM ET
  Executive panel discussion on Wednesday, September 28^th at 1:00 PM ET

• Bank of America Healthcare Innovation Forum (Virtual)
  Spatial Biology & Single Cell panel discussion on Thursday, September 29^th at 11 AM ET
  

A live and archived webcast of the Morgan Stanley Global Healthcare Conference will be available on the “Investors” section of the Akoya website at https://investors.akoyabio.com/.

About Akoya Biosciences
As The Spatial Biology Company^®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. Akoya offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research via its key platforms: PhenoCycler™, PhenoImager™ Fusion and PhenoImager HT. To learn more about Akoya, visit www.akoyabio.com.

Investor Contact:
Priyam Shah
Sr. Director, Investor Relations
Akoya Biosciences, Inc.
investors@akoyabio.com

Media Contact:
Christine Quern
(617) 650-8497
media@akoyabio.com 

FAQ

What investor conferences will Akoya Biosciences participate in September 2022?

Akoya Biosciences will participate in the H.C. Wainwright, Morgan Stanley, Capital One, and Bank of America investor conferences in September 2022.

When is Akoya's presentation at the H.C. Wainwright Conference?

Akoya's presentation at the H.C. Wainwright Conference is scheduled for September 12, 2022, at 11:30 AM ET.

What is the date and time of Akoya's fireside chat at the Morgan Stanley Conference?

The fireside chat at the Morgan Stanley Conference is on September 14, 2022, at 8:35 AM ET.

When will Akoya be part of the Capital One Spatial Biology Summit?

Akoya will participate in the Capital One Spatial Biology Summit on September 28, 2022, at 10:15 AM and 1:00 PM ET.

What time does Akoya's panel discussion occur at the Bank of America Healthcare Innovation Forum?

Akoya's panel discussion at the Bank of America Healthcare Innovation Forum is scheduled for September 29, 2022, at 11 AM ET.